BA
OXFD

Boston Advisors’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Boston Advisors’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$2.12M Buy
127,744
+41,643
+48% +$576K 0.11% 241
2019
Q2 		$1.19M Sell
86,101
-645
-0.7% -$9.86K 0.06% 321
2019
Q1 		$1.5M Sell
86,746
-155
-0.2% -$2.45K 0.08% 265
2018
Q4 		$1.11M Buy
86,901
+7,645
+10% +$116K 0.06% 293
2018
Q3 		$1.29M Buy
+79,256
New +$1.13M 0.06% 334

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Boston Advisors's OXFD Position: Q3 2019 in Review

Boston Advisors increased its Oxford Immunotec Global PLC Ordinary Shares (OXFD) stake by 48% in Q3 2019, buying an estimated $576K and bringing the position to 127,744 shares worth $2.12M. The position accounts for 0.11% of the portfolio, ranked #241.

Boston Advisors first reported a position in OXFD in Q3 2018 and has held it in 5 quarters since. 73 funds tracked by Wall St. Rank hold OXFD as of Q3 2019.

  • Boston Advisors held 127,744 shares of Oxford Immunotec Global PLC Ordinary Shares worth $2.12M as of Q3 2019.
  • Boston Advisors bought 41,643 Oxford Immunotec Global PLC Ordinary Shares shares in Q3 2019, an estimated $576K.
  • Oxford Immunotec Global PLC Ordinary Shares made up 0.11% of Boston Advisors's portfolio in Q3 2019, its #241 holding.
  • Boston Advisors first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q3 2018 and has held it in 5 quarters since.
  • 73 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.